• 1. A survey of pendant donor-functionalised (N,O) phosphine ligands for Cr-catalysed ethylene tri- and tetramerisation
  James A. Suttil,Peter Wasserscheid,David S. McGuinness,Michael G. Gardiner,Stephen J. Evans Catal. Sci. Technol. 2014 4 2574
• 2. One-pot synthesis of tetrasubstituted pyrazoles—proof of regiochemistry
  Ulf Hanefeld,Charles W. Rees,Andrew J. P. White,David J. Williams J. Chem. Soc. Perkin Trans. 1 1996 1545
• 3. 73. Cyclic meso-ionic compounds. Part I. The structure of the sydnones and related compounds
  Wilson Baker,W. D. Ollis,V. D. Poole J. Chem. Soc. 1949 307

Cyclohexylhydrazine hydrochloride (CAS No. 24214-73-1): A Comprehensive Overview

Cyclohexylhydrazine hydrochloride, identified by its Chemical Abstracts Service (CAS) number 24214-73-1, is a compound of significant interest in the field of pharmaceutical chemistry and bioorganic synthesis. This compound, a salt form of cyclohexylhydrazine, has garnered attention due to its versatile applications in medicinal chemistry and potential roles in the development of novel therapeutic agents.

The structural integrity of Cyclohexylhydrazine hydrochloride is characterized by a cyclohexyl group attached to a hydrazine moiety, which is further protonated to form the hydrochloride salt. This structural configuration imparts unique chemical properties that make it a valuable intermediate in synthetic chemistry. The cyclohexyl group contributes to steric hindrance, influencing the reactivity and selectivity of the compound in various chemical transformations.

In recent years, Cyclohexylhydrazine hydrochloride has been explored in the context of drug discovery and development. Its hydrazine moiety is particularly noteworthy, as hydrazine derivatives are well-documented for their pharmacological activities. Studies have demonstrated that hydrazine-based compounds can exhibit anti-inflammatory, antioxidant, and even anticancer properties. The incorporation of the cyclohexyl group into these derivatives aims to modulate the pharmacokinetic profile, enhancing bioavailability and reducing potential side effects.

One of the most compelling areas of research involving Cyclohexylhydrazine hydrochloride is its application in the synthesis of heterocyclic compounds. Heterocycles are fundamental structures in many pharmaceuticals, and the ability to efficiently incorporate functional groups like hydrazine into these frameworks is highly desirable. Researchers have leveraged Cyclohexylhydrazine hydrochloride as a precursor in constructing complex molecular architectures, including imidazoles, pyrimidines, and triazines. These heterocycles are known for their broad spectrum of biological activities, making them attractive candidates for further medicinal chemistry investigations.

The reactivity of Cyclohexylhydrazine hydrochloride also makes it a useful tool in organic synthesis. It can participate in various reactions such as condensation reactions with carbonyl compounds to form hydrazones, which are pivotal intermediates in many synthetic pathways. Additionally, it can undergo cyclization reactions to form nitrogen-containing heterocycles, further expanding its utility in constructing complex molecular entities.

Recent advancements in computational chemistry have also highlighted the importance of Cyclohexylhydrazine hydrochloride in drug design. Molecular modeling studies have been conducted to understand its interactions with biological targets, providing insights into potential binding modes and affinity. These computational approaches complement experimental efforts, enabling researchers to design more effective derivatives with optimized pharmacological properties.

The pharmaceutical industry has shown particular interest in developing novel therapeutics based on hydrazine derivatives. While traditional hydrazines have faced challenges due to their potential toxicity, modifications such as the introduction of bulky groups like cyclohexyl can mitigate these concerns. Current research focuses on identifying derivatives of Cyclohexylhydrazine hydrochloride that exhibit high efficacy while minimizing adverse effects. This involves rigorous screening processes, including in vitro assays and preclinical studies.

In conclusion, Cyclohexylhydrazine hydrochloride (CAS No. 24214-73-1) represents a fascinating compound with diverse applications in pharmaceutical chemistry and synthetic biology. Its unique structural features and reactivity make it a valuable building block for developing new drugs and exploring complex chemical transformations. As research continues to uncover its potential, this compound is poised to play an increasingly significant role in the advancement of medicinal chemistry and drug discovery.

• 98948-63-1(Hydrazine,(1-methyloctyl)-)
• 92379-99-2(Hydrazine, cyclooctyl-,hydrochloride (1:1))
• 57369-89-8(CYCLOOCTYLHYDRAZINE)
• 30929-57-8(Hydrazine, cyclohexyl-,hydrochloride (1:?))
• 17630-34-1(CYCLOHEPTYLHYDRAZINE)
• 24214-72-0(cyclopentylhydrazine;hydrochloride)
• 213325-16-7(Hydrazine,(1-ethylheptyl)-)
• 6498-34-6(Cyclohexylhydrazine)
• 645372-27-6(cyclopentylhydrazine;dihydrochloride)
• 79201-43-7(1-Cycloheptylhydrazine hydrochloride)